Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-08-17
1997-05-27
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540509, C07D24324, A61K 31395
Patent
active
056332513
ABSTRACT:
This invention is concerned with novel compounds represented by structural formula I ##STR1## where R.sup.1 is ##STR2## X and Y are independently hydrogen, fluoro, chloro, bromo, iodo, or trifluoromethyl;
n is 0, 1 or 2; and
R.sup.2 is hydrogen, fluoro, chloro, bromo, iodo, or trifluoromethyl, methyl, or methoxy;
as the racemates, mixtures of enantiomers, individual diastereomers or individual enantiomers, and pharmaceutically acceptable crystal forms, salts, or hydrates thereof.
REFERENCES:
patent: 4820834 (1989-04-01), Evans et al.
patent: 5153191 (1992-10-01), Woodruff
patent: 5166151 (1992-11-01), Freidinger et al.
patent: 5220018 (1993-06-01), Bock et al.
patent: 5324726 (1994-06-01), Bock et al.
Claremon David A.
Liverton Nigel
Selnick Harold G.
Bigley Francis P.
Daniel Mark R.
Ford John M.
Merck & Co. , Inc.
LandOfFree
N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2329234